학술논문

Non-adherence is the most important risk factor for ledipasvir/sofosbuvir HCV treatment failure in the real world
Document Type
Journal
Source
HEPATOLOGY; OCT 2016, 63 1 SUPP, p981A-p982A, 2p.
Subject
Language
English
ISSN
15273350